IDH1 and glioblastoma: Consequently, we found that OS differed significantly between the high-risk (n = 70) and low-risk groups (n = 69) in IDH-wildtype GBM patients in the TCGA cohort (median OS = 9.27 vs. 15.57 months; P = 0.0003; Figure 3F).